Industry

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced the publication of an assessment of the performance of multiple sequential cycles of Eversense 90 and 180-day CGM System use … [Read more…]

NORTH BILLERICA, Mass.–(BUSINESS WIRE)–Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced Mary Anne Heino, President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (NASDAQ: NXGN) will host its annual Investor and Analyst Day on Thursday, December 12, 2019, in New York City from 1:00 p.m. to 3:30 p.m, with lunch and registration beginning at 12:30 p.m. This event is designed for sell-side research analysts and institutional investors and will focus on the Company’s … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery announced today the acquisition of its independent distribution partner, Exactech Italia S.p.A., creating a new corporate subsidiary, effective Nov. 21, 2019. The purchase included all shares of the Province of Brescia-based importer and distributor of Exactech’s orthopaedic … [Read more…]

Webcast and Conference Call today at 4:30 p.m. ET Initiation of RSVP, a Phase 2b study of EDP-938 in adult outpatients with RSV EDP-297 selected as follow-on FXR agonist with differentiated preclinical profile Royalty revenue for the quarter was $51.3 million Cash and marketable securities totaled approximately $400 million at September 30, 2019 WATERTOWN, Mass.–(BUSINESS … [Read more…]

Large independent agency announces latest senior hire in series of moves that support ongoing growth and build for the future TORONTO & NEW YORK–(BUSINESS WIRE)–Klick Health today announced that seasoned healthcare marketing strategist Carl Turner has joined its growing team as Chief Brand Strategy Officer in a move that will help cement the independent hypergrowth … [Read more…]

Two Phase III CALQUENCE trials demonstrated superior progression-free survival across multiple settings while maintaining favorable tolerability CALQUENCE combined with obinutuzumab and as monotherapy reduced the risk of disease progression or death by 90% and 80%, respectively in ELEVATE-TN WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved CALQUENCE® (acalabrutinib) … [Read more…]

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the LONGBOW Titanium Lateral Expandable Spacer System. “We are thrilled to be releasing a Titanium version … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients … [Read more…]

Funding Round Led by Thrive Capital Kareem Zaki, General Partner at Thrive Capital, joins Board of Directors NEW YORK–(BUSINESS WIRE)–Rightway Healthcare, a New York-based patient navigation and healthcare advocacy platform for employers and their employees, today announced it secured $20 million in a Series B funding round led by Thrive Capital. The financing will be … [Read more…]